Drugmaker Dendreon files for Chapter 11 bankruptcy reorganization - ...

11/10/14

Drugmaker Dendreon files for Chapter 11 bankruptcy reorganization
Fox Business
The prostate cancer drug developer Dendreon is seeking Chapter 11 bankruptcy protection and says it has reached a financial restructuring agreement with investors holding more than $520 million in debt. The Seattle company listed more than $664 million ...